Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.58 USD | +3.70% | -7.80% | +65.33% |
Mar. 26 | Stifel Adjusts Spyre Therapeutics' Price Target to $54 From $36, Maintains Buy Rating | MT |
Mar. 18 | Spyre Therapeutics, Inc. announced that it expects to receive $180.005 million in funding | CI |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.